Meribank Biotech Co., Ltd.

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Mesenchymal Stem Cells for Frailty Syndrome	Frailty, Pathologic Processes, Pathological Conditions, Signs and Symptoms	Active, not recruiting	Phase 1 / Phase 2	2024-07-15		NCT06501066
Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells	Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder	Recruiting	Phase 2	2024-07-08		NCT06491043

Clinical trials